Le Lézard
Classified in: Health, Business
Subjects: SVY, PET, ANW

Canine Journal Ranks Healthy Paws Pet Insurance #1


SEATTLE, Aug. 2, 2018 /PRNewswire/ -- Healthy Paws Pet Insurance - the #1 customer-rated provider of insurance for dogs and cats ? has been listed as the "Best Dog Insurance" provider by Canine Journal, the experts on "all things dog." The site performed a third quarter audit of pet insurance providers, and after some tough competition, chose Healthy Paws due to consistent pricing and stellar customer reviews.

Healthy Paws ranked #1 pet insurance again by Canine Journal.

Canine Journal researches pet insurance providers by using customer reviews and social media commentary. They determined Healthy Paws' overall ranking is 4.65 out of 5.00, the highest of all the providers. The following were bonuses to the Healthy Paws ranking:

"We see more companies getting in to pet insurance every week but Healthy Paws remains the picture of stability in this ever-changing world," says Michelle Schenker, co-founder of CanineJournal.com. "We give them top marks for being among the best priced product while giving every customer the assurance of coverage without any caps on payouts for the lifetime of their pet's policy."

"We count Canine Journal as one of the most important resources out there for pet parents," says Rob Jackson, CEO of Healthy Paws Pet Insurance. "So, their stamp of approval is very important. By getting the word out about Healthy Paws, they're helping us give more pets the opportunity for top notch medical care, which can save more lives."

To compare Healthy Paws with other pet insurance providers, check out Canine Journal's comparison reviews for 2018 and get the company's ranking and scores for policy, customer service, claim payments and more.

About Healthy Paws Pet Insurance® 
Healthy Paws is one of the leading pet insurance program providers in the U.S. for dogs and cats and ranked #1 by customers on leading review websites. Policies are underwritten and issued by ACE American Insurance Company, Indemnity Insurance Company of North America, ACE Property & Casualty Insurance Company, Atlantic Employers Insurance Company, members of the Chubb Group. For more information about Healthy Paws Pet Insurance, visit https://www.healthypawspetinsurance.com.

About Canine Journal® 
CanineJournal.com is a leading dog lifestyle website that regularly publishes educational information to help dog owners lead a better life with their pets. As an authority on all-things dog, Canine Journal has been a resource for pet owners providing advice, tips and ways to keep canines safe, healthy and happy since 2007. The team at CanineJournal.com publishes their pet insurance comparison results on an annual basis.

 

SOURCE Healthy Paws Pet Insurance


These press releases may also interest you

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...

at 16:42
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...

at 16:27
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...

at 16:19
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....

at 16:10
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...

at 16:10
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...



News published on and distributed by: